News Summary: K-V Pharma files Chapter 11 Associated Press Copyright 2012 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed. Published 1:24 p.m., Monday, August 6, 2012 CHAPTER 11: K-V Pharmaceutical Co. filed for Chapter 11 bankruptcy protection Saturday, saying weak sales of its preterm birth drug Makena and regulatory sanctions are hurting its business. REORGANIZING: The St.

Topics:  summary   copyright   published   august   k-v pharmaceutical co   reorganizing   st louis   shares   new york stock   exchange   k-v pharma   chapter   press   chapter   k-v   makena   drug   business   hurting   sanctions   sales   

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News